May 10, 2016
Clinical Trials (vol. 13, no. 2, 2016) is available online by subscription only.
- “Key Cost Drivers of Pharmaceutical Clinical Trials in the United States” by Aylin Sertkaya, et al.
- “Lessons Learned: Infrastructure Development and Financial Management for Large, Publicly Funded, International Trials” by Gregg S. Larson, et al.
- “Risks of Phase I Research with Healthy Participants: A Systematic Review” by Rebecca A. Johnson, et al.
- “Should Consent Forms Used in Clinical Trials Be Translated into the Local Dialect? A Survey among Past Participants in Rural Ghana” by Frank Baiden, et al.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.